BiotechTube
Home/NephroDi Therapeutics/Rachael Hagan
RH

Rachael Hagan

President & Chief Executive Officer

NephroDi Therapeutics

Therapeutic Areas

NephrologyRare DiseasesPediatrics

NephroDi Therapeutics Pipeline

DrugIndicationPhase
AMPK Activator for NDICongenital Nephrogenic Diabetes Insipidus (NDI) in childrenPreclinical

Leadership Team at NephroDi Therapeutics

JM
Jeff M. Sands
Chief Medical Officer & Founder
View full NephroDi Therapeutics profile